Back to Journals » Vascular Health and Risk Management » Volume 8

The effects of fatigue, pain, and depression on quality of life in ischemic stroke patients: The Bergen Stroke Study

Authors Naess H, Lunde L, Brogger J

Received 9 April 2012

Accepted for publication 3 May 2012

Published 27 June 2012 Volume 2012:8 Pages 407—413

DOI https://doi.org/10.2147/VHRM.S32780

Review by Single-blind

Peer reviewer comments 2

Halvor Naess,1 Lene Lunde,2 Jan Brogger1

1Department of Neurology, Haukeland University Hospital, 2Department of Economics, University of Bergen, Bergen, Norway

Background: Many patients with cerebral infarction suffer from symptoms such as pain, fatigue, and depression. The aim of this study was to evaluate these symptoms in relation to health-related quality of life (HRQoL) on long-term follow-up.
Materials and methods: All surviving stroke patients admitted to the Stroke Unit, Haukeland University Hospital, Norway between February 2006 and November 2008 were sent a questionnaire, including a visual analog pain scale, Fatigue Severity Scale, Depression Subscale of Hospital Anxiety and Depression Scale, Barthel Index, and three measures of HRQoL – 15D, EuroQol, and EuroQol Visual Analogue Scale – at least 6 months after stroke onset. Cox regression survival analysis, including EQ-5D, was performed by November 2009.
Results: The questionnaire was returned by 328 patients. All three symptoms were reported by 10.1% of the patients, and 26% reported two symptoms. There was a significant association between worse HRQoL scores and an increasing number of cooccurring symptoms for all three HRQoL scores. Fatigue, depression, pain, functional state, and sleeping disorder on follow-up accounted for 58%–83% of the variability in HRQoL, depending on which HRQoL scale was used. Cox regression analysis showed that mortality was associated with a low EuroQol score (P = 0.016).
Conclusion: Pain, fatigue, and depression were common symptoms among these stroke patients and, to a large extent, they determined the patients' HRQoL. Low HRQoL was associated with increased mortality.

Keywords: cerebral infarction, symptoms, mortality

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Comparing withdrawal and not withdrawal of life-sustaining treatment among patients who died from stroke

Helvig E, Thomassen L, Waje-Andreassen U, Naess H

Vascular Health and Risk Management 2015, 11:507-510

Published Date: 3 September 2015

Decline of arterial cerebral infarction among young women: the Bergen Stroke Study

Halvor Naess, Annette Fromm, Ole Erik Iversen, et al

Vascular Health and Risk Management 2011, 7:81-84

Published Date: 15 February 2011

Readers of this article also read:

Hypercalcemia of malignancy and new treatment options

Sternlicht H, Glezerman IG

Therapeutics and Clinical Risk Management 2015, 11:1779-1788

Published Date: 4 December 2015

Physical activity in patients with type 2 diabetes and hypertension – insights into motivations and barriers from the MOBILE study

Duclos M, Dejager S, Postel-Vinay N, di Nicola S, Quéré S, Fiquet B

Vascular Health and Risk Management 2015, 11:361-371

Published Date: 29 June 2015

Resolution of vitreomacular traction following intravitreal ranibizumab in cases of ocular toxoplasmosis with choroidal neovascularization

Petrou P, Georgalas I, Markomichelakis N, Vergados I, Gianakaki E, Rouvas A

Therapeutics and Clinical Risk Management 2013, 9:391-394

Published Date: 18 October 2013

The potential benefit of stem cell therapy after stroke: an update

Banerjee S, Williamson DA, Habib N, Chataway J

Vascular Health and Risk Management 2012, 8:569-580

Published Date: 10 October 2012

Everolimus-eluting stents in interventional cardiology

Townsend JC, Rideout P, Steinberg DH

Vascular Health and Risk Management 2012, 8:393-405

Published Date: 27 June 2012

Percutaneous mechanical thrombectomy for treatment of acute femoropopliteal bypass occlusion

Lichtenberg M, Käunicke M, Hailer B

Vascular Health and Risk Management 2012, 8:283-289

Published Date: 4 May 2012

Absorbable stent: focus on clinical applications and benefits

Gonzalo N, Macaya C

Vascular Health and Risk Management 2012, 8:125-132

Published Date: 29 February 2012

Challenges for heart disease stem cell therapy

Hoover-Plow J, Gong Y

Vascular Health and Risk Management 2012, 8:99-113

Published Date: 17 February 2012

Doppler ultrasound venous mapping of the lower limbs

Galeandro AI, Quistelli G, Scicchitano P, Gesualdo M, Zito A, Caputo P, Carbonara R, Galgano G, Ciciarello F, Mandolesi S, Franceschi C, Ciccone MM

Vascular Health and Risk Management 2012, 8:59-64

Published Date: 7 February 2012